Filter
2513
Filtered Results: 2513
Text search:
Global
TB
Programme
Featured
Recommendations
205
New Publications
692
Language
Document type
No document type
1613
Studies & Reports
388
Guidelines
252
Strategic & Response Plan
93
Manuals
87
Fact sheets
29
Training Material
21
Situation Updates
16
Infographics
8
Resource Platforms
5
Brochures
1
Countries / Regions
India
107
Global
94
Kenya
82
South Africa
82
Western and Central Europe
71
Zambia
59
Malawi
51
Nepal
50
Tanzania
49
Uganda
49
Sierra Leone
48
Namibia
46
Nigeria
45
Eastern Europe
44
Africa
43
Ghana
42
Myanmar / Burma
42
Ethiopia
41
Lesotho
34
Bangladesh
33
Senegal
31
Liberia
29
Asia
28
Ukraine
27
Rwanda
25
South–East Asia Region
25
Congo, Democratic Republic of
24
Zimbabwe
22
Cambodia
18
Latin America and the Carribbean
16
Burkina Faso
14
Benin
13
Mozambique
13
South Sudan
13
Indonesia
13
Haiti
12
Russia
12
Cameroon
11
East and Southern Africa
11
Central African Republic
10
Botswana
10
Pakistan
10
Syria
9
Philippines
9
Madagascar
9
Colombia
8
Guinea
8
Albania
7
Tajikistan
6
Armenia
6
West and Central Africa
6
Middle East and North Africa
6
Georgia
6
Eswatini/ Swaziland
6
Sudan
5
Yemen
5
Afghanistan
4
Burundi
4
Venezuela
4
Western Pacific Region
4
Eastern Europe and Central Asia
4
Bolivia
4
Brazil
4
Laos
3
Peru
3
Jordan
3
Germany
3
Southern Africa
3
Argentina
3
Lebanon
3
Moldova
3
Sri Lanka
3
Somalia
3
North Macedonia
2
Timor Leste/ East Timor
2
Thailand
2
El Salvador
2
Iran
2
Niger
2
Morocco
2
Saudi Arabia
2
Vietnam
2
Angola
2
Bhutan
2
Iraq
2
North Korea
1
Mexico
1
Turkey
1
Gambia
1
Togo
1
Qatar
1
Bulgaria
1
Guinea-Bissau
1
Ireland
1
Paraguay
1
North America
1
Gabon
1
Uruguay
1
Turkmenistan
1
Jamaica
1
Belgium
1
Maldives
1
Tunisia
1
Spain
1
Belarus
1
Côte d’Ivoire / Ivory Coast
1
Nicaragua
1
Djibouti
1
Egypt
1
Romania
1
Greece
1
Palestine
1
Honduras
1
Mali
1
Chad
1
Libya
1
Guatemala
1
Authors & Publishers
Publication Years
Category
Countries
1069
Clinical Guidelines
172
Public Health
109
Key Resources
65
Women & Child Health
64
Pharmacy & Technologies
31
Capacity Building
25
Toolboxes
TB
502
HIV
396
AMR
94
COVID-19
82
NTDs
56
Mental Health
51
Health Financing Toolbox
48
Caregiver
46
Global Health Education
44
Disability
38
NCDs
34
Refugee
28
Ebola & Marburg
28
Conflict
27
Planetary Health
23
Pharmacy
23
Rapid Response
19
Polio
16
Natural Hazards
13
Malaria
13
Zika
4
Social Ethics
3
Specific Hazards
2
South Sudan
1
Cholera
1
Patients with retreatment tuberculosis (TB) represent those
who have been treated previously for onemonth ormorewith
anti-TB drugs and who have been diagnosed once again with
the disease.These patientsmainly include relapses, treatment
after failure, or loss to follow-up on a first-line treatmen...
La lutte contre la tuberculose est une des priorités du ministère de la santé. C’est ainsi que le Plan Stratégique National de lutte contre la Tuberculose 2013-2017 du Sénégal a inscrit dans son programme d’actions la préoccupation de mieux d’améliorer la prise en charge des personnes ...
Migration Health Division Information Sheet Series
Migration Health Assistance for Crisis-Affected Populations
HIV/AIDS, TB, Malaria, Cholera, Re/Emerging Diseases and Mobility
NOVEMBER 2012
This document serves as an update to “Out of the Dark”, a report published by MSF in October 2011, highlighting the need to prioritise the long-neglected area of paediatric tuberculosis (TB). This update will outline the key improvements and setbacks—the ‘highlights’ and ‘...
This rapid communication outlines the main outcomes of a WHO convened Guideline Development Group (GDG) meeting, held in May-June 2021 on the topic of the management of TB in children and adolescents. The rapid communication aims to inform staff from ministries of health and care providers across p...
Improving the management of childhood tuberculosis within national tuberculosis programmes: research priorities based on a literature review
WHO/HTM/TB/2007.381, 07.02
WHO working group on HIV incidence assays meeting report
10–11 December 2015
Glion, Switzerland
UNAIDS/WHO working group on global HIV/AIDS and STI surveillance
WHO/HIV/2017.03
Tuberculosis (TB) is, and should be, a curable disease; however, each year significant numbers of patients acquire or develop drug-resistant TB, which has a much lower cure rate. Patients with drug-resistant TB have a high prevalence of symptoms; hence, staff caring for these patients should h...
Int J Tuberc Lung Dis. 2019 Jul 1;23(7):858–864.Namibia ranks among the 30 high TB burden countries worldwide. Here, we report results of the second nationwide anti-TB drug resistance survey. To assess the prevalence and trends of multidrug-resistant TB (MDR-TB) in Namibia.
From 2014 to 2015, pat...
WHO today released its first roadmap to tackle postpartum haemorrhage (PPH) – defined as excessive bleeding after childbirth - which affects millions of women annually and is the world’s leading cause of maternal deaths.
Despite being preventable and treatable, PPH results in around 70 000 de...
Pathogen genomic surveillance has become a priority for public health systems in recent years. Genomic sequencing is increasingly being used to characterize pathogens and monitor important public health priorities (e.g. poliovirus, influenza virus, Mycobacterium tuberculosis and Vibrio cholerae, ant...
Global HIV Strategic Information Working Group
For Populations At Risk For HIV
WHO’s Country Cooperation Strategy (CCS) defines the Organization’s medium-term vision for working in and with a particular country. The CCS, developed in the context of global and national health priorities, examines the overall health situation in a country, including the state of the health s...
Building on the 2021 Interim guidance, this second version and update, incorporates the lessons and feedback from the hepatitis pilots that successfully demonstrated the feasibility of measuring hepatitis B and C impact targets to demonstrate elimination, whilst highlighting challenges caused by hig...
Global HIV Strategic Information Working Group
NATIONAL HIV/AIDS/STI/TB COUNCIL DEVOLUTION PLAN
Joint United Nations Programme on HIV/AIDS (UNAIDS).
There has never been a more critical moment to invest in WHO, and strengthen the unique role it plays in global health. Now is the time to sustainably finance WHO and invest in a healthy return for all.
Tuberculosis (TB) is the leading cause of death from a single infectious agent even if is largely curable and
preventable. In 2019 an estimated 2.9 million of the 10 million people who fell ill with TB were not
diagnosed or reported to the World Health Organization1. The Politi...
